Joseph Truitt, Chief Commercial Officer at ACHILLION PHARMACEUTICALS INC (ACHN), bought 3,500 shares at $4.06 ($14K) on 2016-12-02, disclosed to the SEC on 2016-12-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ACHN | SELL | 2014-08-26 | $271K | — | Filing → |
| ACHN | SELL | 2014-06-17 | $196K | — | Filing → |
| ACHN | SELL | 2014-06-11 | $301K | — | Filing → |